Usage and Plan of Care Changes Due to Drug Screenings

Clinical Researcher Experience Assessment Documenting Usage and Plan of Care Changes Due to Drug Screenings ©

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02995278

Enrollment

2000

Registered

2016-12-16

Start date

2016-10-31

Completion date

2020-10-31

Last updated

2019-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Management

Brief summary

The purpose of this minimal risk, observational survey is to document the accuracy, benefits, and how qualitative and quantitative results affect patients' plan of care.

Detailed description

Pain is the most common reason patients consult primary care providers. According to recent surveys, One in six Americans live with chronic or recurrent pain and pay an estimated $120 billion a year in medical costs in the United States. Oral opioids are the common treatment options for various chronic pains including joint pain, musculoskeletal pain, neuropathic pain and migraines. This narcotic-based management of pain is often associated with undesirable side effects with addictive and potential abuse. To ensure proper usage of prescribed medications, physicians use drug screens to monitor therapeutic levels and test for presence of illegal drugs or medications that may cause a drug-drug interaction. Upon receiving quantitative or qualitative results from these drug screens, the physician may change the treatment plan for patients to improve efficacy of prescribed medications.

Interventions

OTHERDoes not include a drug needing FDA approval and therefore it is not by definition, a Clinical Drug Trial as defined by FDA.

Study design

Observational model

OTHER

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to 64 Years

Healthy volunteers

Yes

Inclusion criteria

* Must be a Medical Practioner * Medical Doctor (MD) * Doctor of Osteopathic (DO) * Physician Assistant (PA) * Advanced Practice Registered Nurse (APRN) * Nurse Practioner (NP) * Must have a current standard operating procedure that includes obtaining/reviewing medical history.

Exclusion criteria

* Government-funded insurance data cannot be included in the study.

Design outcomes

Primary

Measure	Time frame	Description
Plan of Care Changes due to Drug Screenings	3 years	Provider based observational survey

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026